PostScription: The Home Field Advantage

Sign On

Author(s): Cabaleiro Joe

Issue: Jan/Feb 2016 - Volume 20, Number 1
View All Articles in Issue

Abstract:

Related Keywords: Joe Cabaleiro, RPh, non-U.S. compounders, U.S. Food and Drug Administration, FDA, quality control, regulation

Related Categories: BUSINESS, LEGAL, QUALITY CONTROL

Printer-Friendly Version

Download in electronic PDF format for $35

Title (Click for Abstract / Details)	Author	Issue	Page	View/Buy

Related Articles from IJPC
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines	Allen Loyd V Jr	Jul/Aug 2016	351	View Sample
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs	Allen Loyd V Jr	Sep/Oct 2017	356	Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances	Miller David G	Jul/Aug 2015	303-305	Buy
Documentation: Records and Reports	Akers Michael J	Sep/Oct 2017	373-380	Buy
U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies	Yoch Doug	Mar/Apr 2017	95-102	Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs	Allen Loyd V Jr	Nov/Dec 2015	487-488	Buy
PostScription: The Home Field Advantage	Cabaleiro Joe	Jan/Feb 2016	86-87	Buy
Standard Operating Procedure: U.S. Food and Drug Administration Inspection--Releasing a Sample to the U.S. Food and Drug Administration	Kupiec Tom, Kemp Jesse	Jul/Aug 2007	326-327	Buy
Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1	Martin Matt	Sep/Oct 2018	401-404	Buy
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists	Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake	Sep/Oct 2015	377-380	Buy